Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer (Q80273822)
Jump to navigation
Jump to search
scientific article published on 04 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer |
scientific article published on 04 May 2007 |
Statements
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer (English)
J A Meyerhardt
K Stuart
C S Fuchs
A X Zhu
C C Earle
P Bhargava
L Blaszkowsky
P Enzinger
R J Mayer
C Lawrence